Alpine Global Management’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-689
Closed -$170K 370
2019
Q4
$170K Buy
+689
New +$68.6K 0.04% 329

Other funds holding NGNE

Alpine Global Management's NGNE Position: Q1 2020 in Review

Alpine Global Management sold out of Neurogene (NGNE) in Q1 2020, closing a stake of 689 shares — an estimated $170K sold.

Alpine Global Management first reported a position in NGNE in Q4 2019 and held it in 1 quarter. The position peaked at $170K in Q4 2019. 60 funds tracked by Wall St. Rank hold NGNE as of Q1 2020.

  • Alpine Global Management reported no remaining Neurogene position as of Q1 2020 after selling out during the quarter.
  • Alpine Global Management sold 689 Neurogene shares in Q1 2020, an estimated $170K.
  • Alpine Global Management first reported a position in Neurogene in Q4 2019 and held it in 1 quarter.
  • Alpine Global Management's Neurogene position peaked at $170K in Q4 2019.
  • 60 funds tracked by Wall St. Rank held Neurogene as of Q1 2020.

Based on Alpine Global Management's 13F filing for Q1 2020, filed 9 Apr 2020.